{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T11:28:28Z","timestamp":1715858908774},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s00066-009-2043-3","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T10:04:00Z","timestamp":1249293840000},"page":"488-492","source":"Crossref","is-referenced-by-count":15,"title":["Die Rolle der Magnetresonanztomographie f\u00fcr die Indikationsstellung zur pr\u00e4operativen Therapie beim Rektumkarzinom"],"prefix":"10.1007","volume":"185","author":[{"given":"Claus","family":"R\u00f6del","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,4]]},"reference":[{"key":"2043_CR1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1148\/radiol.2323031368","volume":"232","author":"S. Bipat","year":"2004","unstructured":"Bipat S, Glas AS, Slors FJ, et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - a meta-analysis. Radiology 2004;232:773\u201383.","journal-title":"Radiology"},{"key":"2043_CR2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/02841860701348670","volume":"46","author":"H. Birgisson","year":"2007","unstructured":"Birgisson H, Pahlman L, Gunnarsson U, et al. Late adverse effects of radiation therapy for rectal cancer \u2014 a systematic overview. Acta Oncol 2007;46:504\u201316.","journal-title":"Acta Oncol"},{"key":"2043_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-2006-947279","volume":"131","author":"H.J. Buhr","year":"2006","unstructured":"Buhr HJ, Dommisch K, Fleischer GM, et al. [Clinical pathway (workflow) for diagnostic, therapy and follow-up in patients with rectal cancer.] Zentralbl Chir 2006;131:285\u201397.","journal-title":"Zentralbl Chir"},{"key":"2043_CR4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.bjc.6602947","volume":"94","author":"S. Burton","year":"2006","unstructured":"Burton S, Brown G, Daniels IR, et al. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer 2006;94:351\u20137.","journal-title":"Br J Cancer"},{"key":"2043_CR5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ejca.2008.11.039","volume":"45","author":"M. Dulk den","year":"2009","unstructured":"den Dulk M, Putter H, Collette L, et al. The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer 2009;45:1175\u201383.","journal-title":"Eur J Cancer"},{"key":"2043_CR6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00066-008-1751-4","volume":"184","author":"J. Dunst","year":"2008","unstructured":"Dunst J, Debus J, Rudat V, et al. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. Strahlenther Onkol 2008;184:450\u20136.","journal-title":"Strahlenther Onkol"},{"key":"2043_CR7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-2006-946549","volume":"131","author":"T. Junginger","year":"2006","unstructured":"Junginger T, Hermanek P, Oberholzer K, et al. [Rectal carcinoma: is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication.] Zentralbl Chir 2006;131:275\u201384.","journal-title":"Zentralbl Chir"},{"key":"2043_CR8","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1200\/JCO.2005.05.256","volume":"23","author":"C.A. Marijnen","year":"2005","unstructured":"Marijnen CA, van de Velde CJ, Putter H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2005;23:1847\u201358.","journal-title":"J Clin Oncol"},{"key":"2043_CR9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.38937.646400.55","volume":"333","author":"MERCURY Study Group.","year":"2006","unstructured":"MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006;333:779\u201385.","journal-title":"BMJ"},{"key":"2043_CR10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1148\/radiol.2431051825","volume":"243","author":"MERCURY Study Group.","year":"2007","unstructured":"MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 2007;243:132\u20139.","journal-title":"Radiology"},{"key":"2043_CR11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s003840100309","volume":"16","author":"S. Merkel","year":"2001","unstructured":"Merkel S, Mansmann U, Siassi M, et al. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001;16:298\u2013304.","journal-title":"Int J Colorectal Dis"},{"key":"2043_CR12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00066-008-1731-8","volume":"184","author":"V. Milani","year":"2008","unstructured":"Milani V, Pazos M, Issels RD, et al. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer. Strahlenther Onkol 2008;184:163\u20138.","journal-title":"Strahlenther Onkol"},{"key":"2043_CR13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1200\/JCO.2007.12.7027","volume":"26","author":"I.D. Nagtegaal","year":"2008","unstructured":"Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 2008;26:303\u201312.","journal-title":"J Clin Oncol"},{"key":"2043_CR14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","volume":"246","author":"K.C. Peeters","year":"2007","unstructured":"Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693\u2013701.","journal-title":"Ann Surg"},{"key":"2043_CR15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(09)60485-2","volume":"373","author":"P. Quirke","year":"2009","unstructured":"Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 2009;373:821\u20138.","journal-title":"Lancet"},{"key":"2043_CR16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00066-007-9000-9","volume":"183","author":"C. R\u00f6del","year":"2007","unstructured":"R\u00f6del C, Sauer R. Integration of novel agents into combined-modality treatment for rectal cancer patients. Strahlenther Onkol 2007;183:227\u201335.","journal-title":"Strahlenther Onkol"},{"key":"2043_CR17","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R. Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731\u201340.","journal-title":"N Engl J Med"},{"key":"2043_CR18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1055\/s-2008-1027726","volume":"46","author":"W. Schmiegel","year":"2008","unstructured":"Schmiegel W, Reinacher-Schick A, Arnold D, et al. [Update S3-guideline \u201ccolorectal cancer\u201d 2008.] Z Gastroenterol 2008;46:799\u2013840.","journal-title":"Z Gastroenterol"},{"key":"2043_CR19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","volume":"373","author":"D. Sebag-Montefiore","year":"2009","unstructured":"Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009;373:811\u201320.","journal-title":"Lancet"},{"key":"2043_CR20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00384-008-0531-z","volume":"23","author":"J. Strassburg","year":"2008","unstructured":"Strassburg J, Junginger T, Trinh T, et al. Magnetic resonance imaging (MRI)-based indication for neoadjuvant treatment of rectal carcinoma and the surrogate endpoint CRM status. Int J Colorectal Dis 2008;23:1099\u2013107.","journal-title":"Int J Colorectal Dis"},{"key":"2043_CR21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00423-007-0149-6","volume":"392","author":"J. Strassburg","year":"2007","unstructured":"Strassburg J, Lewin A, Ludwig K, et al. Optimised surgery (so-called TME surgery) and high-resolution MRI in the planning of treatment of rectal carcinoma. Langenbecks Arch Surg 2007;392:179\u201388.","journal-title":"Langenbecks Arch Surg"},{"key":"2043_CR22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.radonc.2008.05.022","volume":"87","author":"V. Valentini","year":"2008","unstructured":"Valentini V, Beets-Tan R, Borras JM, et al. Evidence and research in rectal cancer. Radiother Oncol 2008;87:449\u201374.","journal-title":"Radiother Oncol"},{"key":"2043_CR23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00066-008-1858-7","volume":"184","author":"R.F. Vliegen","year":"2008","unstructured":"Vliegen RF, Beets-Tan RG, Vanhauten B, et al. Can an FDG-PET\/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer? Strahlenther Onkol 2008;184:457\u201364.","journal-title":"Strahlenther Onkol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-2043-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-009-2043-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-2043-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:30:55Z","timestamp":1558578655000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-009-2043-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["2043"],"URL":"https:\/\/doi.org\/10.1007\/s00066-009-2043-3","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}